A Study of LY3435151 in Participants With Solid Tumors
Stopped early · Phase 1
Conditions studied: Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Cervical Carcinoma, High Grade Serous Ovarian Carcinoma, Hepatocellular Carcinoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma
In brief
The reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.
Key facts
- Study ID
- NCT04099277
- Run by
- Eli Lilly and Company
- People needed
- 2
- Starts
- 2019-10-28
- Expected to finish
- 2020-03-05
- Last updated by the study team
- 2021-08-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participant must have certain types of cancer, which your study doctor will discuss with you
- Participant must have stopped other forms of treatment for cancer, which your study doctor will discuss with you
- Participant must be able and willing to provide a sample of your tumor before beginning treatment and once while on treatment. For certain tumor types, the outcome of the biopsy may exclude you from the study treatment (for Phase 1b)
- Participant must agree to use birth control
- Participant must have progressed through or are intolerant to therapies with known clinical benefit, which your study doctor will discuss with you
You may not qualify if…
- Participant must not have a history of tuberculosis, uncontrolled HIV or uncontrolled hepatitis B or C virus infection
- Participant must not have an autoimmune disease, which your study doctor will discuss with you
- Participant must not use corticosteroids, which your study doctor will discuss with you
- Participant must not have heart disease, Crohn's disease or brain cancer
- Participant must not be pregnant or breastfeeding
Where it is running
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- National Cancer Center Hospital — Chuo-Ku, Tokyo, Japan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.